FMP

FMP

Enter

A - Agilent Technol...

photo-url-https://images.financialmodelingprep.com/symbol/A.png

Agilent Technologies, Inc.

A

NYSE

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

121.18 USD

3.85 (3.18%)

Historical Prices

From:

To:

117.5118119120121121.9609:30 AM09:50 AM10:09 AM10:29 AM10:48 AM11:09 AM11:28 AM11:49 AM12:08 PM12:27 PM12:46 PM01:05 PM01:24 PM01:43 PM02:02 PM02:21 PM02:40 PM02:59 PM03:18 PM03:37 PM03:56 PM

About

ceo

Mr. Padraig McDonnell

sector

Healthcare

industry

Medical - Diagnostics & Research

exchange

NYSE

Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imag...

CIK

0001090872

ISIN

US00846U1016

CUSIP

00846U101

Address

5301 Stevens Creek Boulevard

Phone

800 227 9770

Country

US

Employee

17,900

IPO Date

Nov 18, 1999

Financial Statement

0300M600M900M1.2B1.5B1.8B2024 Q12024 Q22024 Q32024 Q42025 Q1RevenueNet Income

Earnings

00.30.60.91.21.52023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q42025 Q1EPS Consensus

A Financial Summary

CIK

0001090872

Exchange

NYSE

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

00846U101

ISIN

US00846U1016

Country

US

Price

121.18

Beta

1.11

Volume Avg.

1.81M

Market Cap

34.55B

Shares

-

52-Week

117.17-155.35

DCF

85.55

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

27.79

P/B

-

Website

https://www.agilent.com

Upgrades and Downgrades

We are unable to load the data!

fmp-logo

Latest A News

Rayan Ahmad

13 hours ago

Bayerische Motoren Werke AG (BMW) Financial Overview

Bayerische Motoren Werke AG, known as BMW, is a leading German automobile manufacturer. Trading under the symbol BAMXF on the PNK exchange, BMW is renowned for its luxury vehicles and motorcycles. The company faces competition from other automotive giants like Mercedes-Benz and Audi. Despite its strong brand presence, BMW is currently navigating financial challenges. On March 14, 2025, BMW reported earnings per share of $2.49, missing the estimated $3.73. The company's revenue was approximately...

Alex Lavoie

13 hours ago

Genmab A/S (NASDAQ:GMAB) Sees Positive Analyst Attention and...

Genmab A/S, trading under the symbol NASDAQ:GMAB, is a biotechnology company known for its innovative antibody therapeutics. Established in 1999 and based in Copenhagen, Denmark, Genmab focuses on developing next-generation antibody technology platforms. The company aims to make a significant impact on the lives of people with cancer and other serious diseases by 2030. In compliance with Article 19 of Regulation No. 596/2014 on Market Abuse, Genmab has disclosed share transactions by its manage...

Davit Kirakosyan

14 hours ago

Semtech Jumps 18% After Strong Q4 Earnings, AI Demand Boosts...

Semtech (NASDAQ:SMTC) surged around 18% intra-day today after reporting better-than-expected fourth-quarter results, fueled by rising demand for AI and machine learning applications that drove data center sales and improved margins. For the quarter, the semiconductor and cloud services provider posted adjusted earnings per share of $0.40, beating analyst expectations of $0.33. Revenue reached $251 million, slightly exceeding the forecasted $250.18 million. Semtech also saw significant margin exp...

Davit Kirakosyan

14 hours ago

Ulta Beauty Jumps 12% on Strong Holiday Quarter

Ulta Beauty (NASDAQ:ULTA) shares surged nearly 12% intra-day today after the cosmetics retailer posted better-than-expected fourth-quarter earnings, driven by strong demand during the holiday season. However, weaker-than-anticipated full-year guidance raised concerns about the impact of economic headwinds on consumer spending. The company reported earnings per share of $8.46 on revenue of $3.5 billion, surpassing analyst expectations of $7.11 EPS and $3.46 billion in revenue. Comparable sales ro...

Davit Kirakosyan

15 hours ago

DocuSign Shares Jump 18% on Strong Earnings

DocuSign (NASDAQ:DOCU) delivered a better-than-expected fourth-quarter earnings report, pushing its stock up over 18% intra-day today. The company posted earnings per share of $0.86, slightly outperforming analyst expectations of $0.84. Revenue for the quarter also exceeded forecasts, reaching $776.3 million, above the $760.99 million consensus estimate. Despite the strong quarter, DocuSign’s outlook for fiscal 2026 came in softer than anticipated. The company expects first-quarter revenue betw...

Rayan Ahmad

18 hours ago

AirSculpt Technologies, Inc. (NASDAQ:AIRS) Faces Financial C...

AirSculpt Technologies, Inc. (NASDAQ:AIRS) is a prominent player in the body contouring industry, known for its innovative and minimally invasive procedures. The company operates 32 centers worldwide and has performed over 70,000 procedures. Despite its strong market presence, AIRS faces stiff competition from other cosmetic surgery providers. The company recently reported its financial results for the fourth quarter and full year ending December 31, 2024. On March 14, 2025, AIRS announced an e...

Alex Lavoie

18 hours ago

Science Applications International Corporation (NASDAQ: SAIC...

Science Applications International Corporation (NASDAQ: SAIC) is a prominent player in the technology integration sector, known for its innovative solutions. As a Fortune 500 company, SAIC focuses on leveraging technology to deliver comprehensive solutions. The company is set to release its fourth-quarter fiscal year 2025 results on March 17, 2025, before the market opens, with a conference call scheduled at 10:00 a.m. Eastern Time. Wall Street anticipates SAIC's earnings per share to be $2, wi...

Alex Lavoie

20 hours ago

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Outperforms...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company is known for its product, WAKIX, which is used to treat excessive daytime sleepiness in adults with narcolepsy. In the competitive landscape, Harmony stands out due to its effective capital utilization, as evidenced by its financial metrics. Harmony Biosciences showcases a Return on Invested Capit...

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep